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Summary
 
Apoptosis of bystander uninfected CD4
 
1
 
 T lymphocytes by neighboring HIV-infected cells is
observed in cell culture and in lymphoid tissue of HIV-infected individuals. This study ad-
dresses whether antigen-presenting cells such as human macrophages mediate apoptosis of
CD4
 
1
 
 T cells from HIV-infected individuals. Uninfected human macrophages, and to a larger
degree, HIV-infected macrophages mediate apoptosis of T cells from HIV-infected, but not
from uninfected control individuals. This macrophage-dependent killing targets CD4
 
1
 
, but not
CD8
 
1
 
 T lymphocytes from HIV-infected individuals, and direct contact between macrophages
and lymphocytes is required. Additional analyses indicated that the apoptosis-inducing ligands,
FasL and tumor necrosis factor (TNF), mediate this macrophage-induced apoptosis of CD4
 
1
 
T cells. These results support a role for macrophage-associated FasL and TNF in the selective
depletion of CD4
 
1
 
 T cells in HIV-infected individuals.
 
T
 
he physiologic regulation of peripheral CD4
 
1
 
 T cell
homeostasis is influenced by the rate of lymphocyte
apoptosis. This form of cell death is tightly regulated and is
dependent upon the expression of a family of ligands (Fas
ligand [FasL], TNF, tumor necrosis factor–related apoptosis-
inducing ligand [TRAIL]) and receptors (Fas, TNFR) that
mediate apoptosis and upon the induction of susceptibility of
these cells to receptor-initiated apoptosis (1–9). Enhanced
apoptosis of peripheral uninfected CD4
 
1
 
 T lymphocytes is
postulated to contribute to CD4
 
1
 
 T cell depletion in HIV-
infected individuals (reviewed in references 10–12). Increased
spontaneous and activation-induced apoptosis of peripheral
CD4
 
1
 
 T cells from HIV-infected individuals is observed ex
vivo (13–15) and in lymph nodes of HIV-infected individuals
and SIV-infected macaques (16, 17). Importantly, a correla-
tion between CD4
 
1
 
 T cell apoptosis and CD4
 
1
 
 T cell de-
pletion has been established in different animal models of
AIDS (18–20).
Accumulating data indicate that the increased level of
CD4
 
1
 
 T cell apoptosis in HIV-infected individuals is due
to an aberrant upregulation of the physiological mechanisms
controlling peripheral CD4
 
1
 
 T cell apoptosis, namely, the
expression level of apoptosis-inducing ligands and receptors
and the state of cell susceptibility to such ligand/receptor
initiated apoptosis. Fas, FasL, TNF, and TNFR are in-
creased in HIV-infected individuals and inversely corre-
lated with CD4
 
1
 
 T cell numbers (21–28). In addition, pe-
ripheral CD4
 
1
 
 T cells from HIV-infected individuals are
highly susceptible to FasL/Fas initiated apoptosis (29, 30).
The mechanisms whereby the level of apoptosis-inducing
receptors/ligands and the state of susceptibility of CD4
 
1
 
 T
cells to apoptosis are increased in the context of HIV infec-
tion are unknown, although gp120 cross-linking of CD4
and 
 
tat
 
 and cytokines may be responsible as demonstrated
in vitro (31–35).
The circumstances whereby a susceptible CD4
 
1
 
 T cell
encounters apoptosis-inducing ligands remains unknown.
In vitro culture models demonstrate that uninfected CD4
 
1
 
T cells undergo apoptosis upon contact by HIV-infected
cells (36, 37). Moreover, in lymph nodes from HIV-infected
individuals or SIV-infected macaques, the CD4
 
1
 
 T cells
that undergo apoptosis are not HIV-infected, but rather in
direct contact with neighboring HIV-infected cells (17).
These observations support the requirement of direct cell
contact between a susceptible CD4
 
1
 
 T cell and a cell that
potentially expresses apoptosis-inducing ligands. Antigen-
presenting cells such as human macrophages are postulated
to play a major role in the physiological deletion/apoptosis
of activated, and hence susceptible, peripheral T lympho-
cytes (38) suggesting that apoptosis-inducing ligands ex-
pressed by macrophages can mediate apoptosis of suscepti-
ble CD4
 
1
 
 T cells. In fact, differentiated macrophages trigger
selective apoptosis of CD4
 
1
 
 T cells that have been rendered
susceptible following CD4
 
1
 
 cross-linking (39). These ob-
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servations, together with the recent identification of FasL
expression in human macrophages and its upregulation by
HIV infection (40), lead to the hypothesis that antigen-pre-
senting cells such as human macrophages may play a major
role both in normal CD4
 
1
 
 T cell homeostasis and in the
enhanced CD4
 
1
 
 T cell depletion observed in HIV-infected
individuals.
In this study, we have evaluated whether human mac-
rophages lead to the selective apoptosis of CD4
 
1
 
 T cells
isolated from HIV-infected individuals. In addition, we have
analyzed whether apoptosis-inducing ligands presumably
present on human macrophages participate in the apoptosis
of CD4
 
1
 
 T cells. Our results demonstrate that human mac-
rophages induce selective apoptosis of CD4
 
1
 
 T lympho-
cytes from HIV-infected individuals through FasL and TNF.
 
Materials and Methods
 
Patient Population and Isolation of Peripheral Blood Mononuclear
Cells.
 
HIV-infected individuals attending the HIV Clinics at
Hennepin County Medical Center (Minneapolis, MN) and Mayo
Clinic (Rochester, MN) were selected based on CD4
 
1
 
 T lym-
phocyte counts of 
 
.
 
100 cells/dl and absence of concomitant
opportunistic infections. After obtaining informed consent, 50 ml
of whole blood was obtained and PBMC were isolated by den-
sity gradient centrifugation (Ficoll Hypaque; Pharmacia LKB Bio-
technology, Inc., Piscataway, NJ). Cells were then cultured in
RPMI 1640 supplemented with 10% AB serum (GIBCO BRL,
Gaithersburg, MD) and adhered to plastic at 37
 
8
 
C in 5% CO
 
2
 
 for
two 1 h periods. The nonadherent cells (PBL) were pelleted and
resuspended in RPMI 1640 10% FBS (Hyclone Laboratories Inc.,
Logan, UT) at a final concentration of 1 
 
3
 
 10
 
6
 
 cells/ml.
Monocyte derived macrophages (MDM)
 
1
 
 were obtained from
PBMC from HIV seronegative healthy individuals. Briefly, PBMCs
were separated from buffy coats by Ficoll Hypaque density gradi-
ent centrifugation, and 10
 
8
 
 cells were resuspended in 50 ml of
RPMI 1640 supplemented with 10% AB serum (GIBCO BRL)
and placed horizontally in a 75 cm
 
2
 
 plastic flask (Corning-Costar,
Cambridge, MA). 6 d later, nonadherent cells were removed by
washing the monolayer three times in RPMI 1640, and adherent
cells (MDM) were either HIV- or mock-infected overnight (see
below).
 
Viral Stocks and HIV Infection.
 
Supernatants from cultures of
PHA-IL2–treated PBMC either infected or not with HIV-SF
 
162
 
(obtained from National Institutes of Health AIDS Reference and
Reagent Program) were collected at days 6 through 10 after in-
fection. Clarified and filtered supernatants were analyzed for p24
content using a commercial ELISA kit (Cellular Products Inc.,
Buffalo, NY), and mycoplasma using a commercial RIA kit
(Fisher, Pittsburgh, PA). Supernatants were then aliquoted and
stored at 
 
2
 
120
 
8
 
C.
HIV infection of MDM was performed by incubating the ad-
herent cell monolayer with 2.5 
 
m
 
g of HIV p24 containing super-
natant per T75 flask of MDM during 24 h at 37
 
8
 
C 5% CO
 
2
 
.
Mock infection was performed by incubating MDM with an
equal volume of mock-infected culture supernatant. After infec-
tion, MDM monolayers were washed extensively and cultured in
10% AB serum (GIBCO BRL). At day 7 after infection, HIV- or
mock-infected MDM were scraped, counted, and reseeded in
24-well plates (Costar) at cell concentrations indicated in each ex-
periment. 5 d later (12 d after infection), cells were used in exper-
iments. Analysis of p24 content in HIV-infected macrophage
supernatants was analyzed by a commercial ELISA kit (Cellular Prod-
ucts Inc.). Flow cytometric evaluation of intracytoplasmic p24
was performed randomly in different batches of HIV-infected MDM
by fluorescein isothiocyanate conjugated p24 antibody (Virostat,
Portland, ME), as previously described (40, 41), demonstrating spe-
cific p24 fluorescein in 15–48% of MDM from a variety of donors.
 
Antibodies and Fusion Proteins.
 
Anti-Fas monoclonal antibod-
ies M3 and M33 were used to determine the involvement of Fas/
FasL interaction. M3 and M33 bind to Fas, but M3 and not M33
blocks ligand induced killing (2, 5, 40). Fusion proteins contain-
ing the Fc portion of mouse IgG1 and the Fas antigen (Fas-Fc),
the TNFR (TNFRFc), or CD40 (CD40-Fc) have been previ-
ously described (40, 41).
 
Determination of Apoptosis in CD4
 
1
 
 or CD8
 
1
 
 T Lymphocytes.
 
Apoptosis was measured using a flow cytometric method previ-
ously described (29, 41). PBL were washed in RPMI 10% AB se-
rum (GIBCO BRL), and resuspended in PBS 0.1% azide. Cells
were then incubated for 15 min at 4
 
8
 
C with 1 
 
m
 
g/10
 
6
 
 cells of both
FITC-labeled anti-CD3 monoclonal antibody (Becton Dickinson,
San Jose, CA) and PE-conjugated anti-CD4 monoclonal anti-
body (CALTAG Labs., South San Francisco, CA) in the presence
of 0.01% sodium azide. Hoechst 33342 (2 
 
m
 
g/ml) (Calbiochem
Corp., La Jolla, CA) was added, and cells were incubated for an
additional 7 min at 4
 
8
 
C. Cells were then washed and resuspended
in ice-cold 0.5% paraformaldehyde in PBS. Flow cytometric
evaluation was performed using a FACSTAR
 
1
 
Ò
 
 flow cytometer.
30,000 events were recorded and apoptosis was separately quanti-
tated in the CD4
 
1
 
 and CD8
 
1
 
 populations. Apoptotic cells were
quantitated by gating on cells with decreased forward angle light
scatter and increased Hoechst-specific fluorescence.
 
Coincubation of Macrophages and PBLs.
 
Unless stated, 5 
 
3
 
 10
 
6
 
HIV- or mock-infected MDM/well in 24-well plates were
washed and incubated for 36 h with 10
 
6
 
 PBL from HIV seroposi-
tive or seronegative individuals. In experiments addressing cell–
cell contact, 6.5 mm transwell porous cell culture inserts (0.4 
 
m
 
m)
(Costar) were placed into wells containing HIV- or mock-infected
MDM. PBL were added to the top of the transwell.
In experiments addressing the role of autologous killing of
PBLs by HIV-infected MDMs, the methodology was as follows.
200 cc of peripheral blood was obtained and MDMs were cul-
tured, HIV infected, and reseeded as above. In the case of the
HIV seronegative individual, 9 d after HIV infection of the
MDMs, an additional 50 ml of peripheral blood was obtained,
and PBLs were isolated and cultured in media containing PHA
(Murex Wellcome, Research Triangle Park, NC) at 10 
 
m
 
g/ml
and IL-2 (Hoffmann-LaRoche, Nutley, NJ) at 60 IU/ml to gen-
erate lymphoblasts. 14 d after HIV infection of MDM, an addi-
tional 50 ml of peripheral blood was drawn from the same indi-
vidual and PBLs were isolated. PHA and IL-2 blasts or freshly
isolated PBLs were then incubated with HIV-infected MDMs in
the presence or absence of M3 or M33 Fab antibodies for 24 h.
PBL blasts, but not freshly isolated PBLs, from the HIV seronega-
tive individual, were shown to be Fas sensitive as demonstrated
by the induction of apoptosis by cross-linked agonist anti-Fas an-
tibody (M3), but not by isotype matched control antibody. In ex-
periments addressing syngeneic apoptosis of CD4
 
1
 
 T cells in an
HIV-infected individual, MDMs were isolated from 300 cc of
peripheral blood from this individual and HIV infected in vitro.
14 d after HIV infection of MDM, PBLs were isolated and coin-
 
1
 
Abbreviation used in this paper:
 
 MDM, monocyte derived macrophage. 
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cubated with HIV-MDM in the presence or absence of M3 or
M33 Fab antibodies for 24 h.
 
Statistical Analysis.
 
Comparison of the amount of apoptosis that
was observed with different HIV seropositive or seronegative PBL
donors after coincubation with either uninfected or HIV-infected
macrophages were made using a one way analysis of variance.
 
Results
 
Primary Human MDM Trigger Apoptosis of CD4
 
1
 
 T Cells
from HIV-infected Individuals.
 
To determine whether MDM
trigger apoptosis of CD4
 
1
 
 T cells, 14-d-old MDM from
HIV seronegative healthy donors were incubated for 36 h
with freshly isolated PBL from HIV-infected individuals or
HIV seronegative healthy donors. Thereafter, nonadherent
cells were harvested and analyzed using flow cytometry to
detect apoptosis within CD4
 
1
 
 or CD8
 
1
 
 T lymphocytes. A
representative example of this analysis is depicted in Fig. 1 
 
A.
 
A minimal degree of CD4
 
1
 
 T cell apoptosis (median of
1.25%) is observed in PBL from HIV seronegative healthy
control donors (Fig. 1 
 
B
 
). However, when MDM are incu-
bated with PBL from HIV-infected individuals, a larger de-
gree of CD4
 
1
 
 T lymphocyte apoptosis is observed (median
of 8.7%, 
 
P
 
 
 
5
 
 0.039) (Fig. 1 
 
C
 
), suggesting enhanced sus-
Figure 1. Apoptosis of CD41 T cells
from HIV seropositive individuals by unin-
fected and HIV-infected macrophages. (A)
Analysis of apoptosis can be performed sepa-
rately on CD41 T lymphocytes (CD3 FITC
positive, CD41 PE positive cells) and on
CD81 lymphocytes (CD3 FITC positive,
CD41 PE negative cells). In the plot de-
picted, 36.9% of cells have decreased for-
ward angle light scatter and increased Hoechst
specific fluorescence, indicating that these
cells are apoptotic within the CD4 popula-
tion (right). (B and C) Uninfected macro-
phages (UNINFECTED MDM) were used
as effector cells at 5:1 effector/target ratio
against PBL from either HIV seronegative
(B) or infected individuals (C). Mean spon-
taneous apoptosis was 7.8 6 4.9% (B), and
23.1 6 15.1% (C). (D and E) The same ex-
periments repeated with HIV-infected
MDM (HIV-MDM) against HIV seronega-
tive (D) or seropositive (E) individuals. Me-
dian spontaneous apoptosis was 8.1 6 4.8%
(D), and 23.0 6 14.8 (E). In B–E, percent
specific apoptosis was calculated by subtract-
ing the amount of apoptosis from PBLs cul-
tured in medium alone from the amount of
apoptosis when the same PBLs were coin-
cubated with macrophages as indicated.58 Apoptosis of CD4 T Lymphocytes from HIV-infected Patients
ceptibility of CD41 T cells from HIV-infected individuals
to MDM-mediated apoptosis.
Previous studies in lymph nodes from HIV-infected in-
dividuals indicate that those cells that are undergoing apop-
tosis are not HIV-infected, but are in direct contact with
HIV-infected ones (17). Therefore, we tested whether HIV
infection of MDM further enhances the MDM-mediated
CD41 T cell apoptosis in PBL from HIV-infected individ-
uals. Using the same experimental design as described above,
PBL from HIV seronegative healthy controls and from HIV-
infected individuals were incubated with 14-d-old HIV-
infected MDM. A significant increase in CD41 T cell
apoptosis is observed in PBL from HIV-infected individu-
als incubated with HIV-MDM (median 16.1%) as com-
pared to the degree of CD41 T cell apoptosis in PBL from
HIV seronegative individuals (median 4.2%, compare Fig. 1,
E and D, P 5 0.001). In addition, HIV-infected MDM, as
compared to uninfected ones, further increase the apoptosis
of CD41 T cells from HIV seronegative individuals (com-
pare Fig. 1 D with B, P 5 0.025) and HIV-infected indi-
viduals (compare Fig. 1, E with C, P 5 0.001).
Altogether, these results indicate that uninfected, and to
a larger degree, HIV-infected MDM selectively induce
apoptosis of CD41 T cells, and that CD41 T cells from
HIV seropositive individuals are inherently more suscepti-
ble to MDM and HIV-MDM–mediated apoptosis.
MDM Trigger Apoptosis of CD41, but not CD81, T Lym-
phocytes. Because CD41 T lymphocytes are preferentially
depleted over CD41 T cells in HIV-infected individuals,
we sought to determine whether MDM induced apoptosis of
T lymphocytes is restricted to CD41 T cells. For this, PBL
from five different HIV seropositive individuals (HIV-PBL)
were incubated with HIV-infected MDM (HIV-MDM) at
different effector (HIV-MDM) to target (HIV-PBL) ratios.
After 36 h of coincubation, PBLs were analyzed using flow
cytometry to determine the level of apoptosis with CD41
and CD81 T cells. Spontaneous apoptosis was higher in
CD81 than CD41 T cells (Fig. 2). Increasing the effector
to target ratio resulted in a progressive increase in the level
of CD41 T cell apoptosis in all patients, an effect that was
not observed in CD81 T lymphocytes from the same HIV-
infected individual (Fig. 2). These results indicate that
MDM can trigger selective apoptosis of susceptible CD41
T lymphocytes.
Cell Contact Is Required for HIV-MDM–mediated Apoptosis of
CD41 T cells from HIV-infected Individuals. Human macro-
phages express apoptosis-inducing ligands such as FasL and
TNF (40, 42). Because these two apoptosis-inducing ligands
may participate in CD41 T cell apoptosis and are known to
be expressed in both cell-associated and soluble form (21),
we investigated whether direct cell contact between MDM
and PBL is required for CD41 T cell apoptosis. HIV- or
mock-infected MDM were coincubated with PBL from
another series of five HIV-infected individuals, in the pres-
ence or absence of transwells. Apoptosis of CD41 T cells
was then analyzed by flow cytometry. CD41 T cell apop-
tosis mediated by mock-infected MDM (NI) was decreased
in the presence of transwells in all patients tested (Fig. 3,
compare lanes 1 and 2). Similarly, the higher level of
CD41 T cell apoptosis mediated by HIV-infected MDM
(HIV) was also decreased in the presence of transwells (Fig.
3, compare lanes 3 and 4). These results support the re-
quirement for direct contact between MDM and PBL to
result in the selective apoptosis of CD41 T cells from HIV-
infected individuals.
Fas/FasL Interactions Participate in the Apoptosis of CD41 T
cells from HIV Seropositive Individuals Triggered by HIV-
MDM. We have previously described that FasL is partly
responsible for the HIV-MDM–mediated apoptosis of Fas
susceptible targets such as Jurkat T cells and PHA-IL2–
Figure 2. HIV-infected macrophages induce selective apoptosis of CD41 T cells from HIV-infected individuals. 106 PBL from HIV-infected and HIV
seronegative healthy individuals were coincubated with varying amounts (0, 1, 2, 5, and 10 3 106/well) of HIV-infected macrophages for 36 h, and
stained with anti-CD3 FITC, anti-CD41 PE, and Hoechst 33342. The observed amounts of apoptosis for CD4 lymphocytes (CD31, CD41) and CD8
lymphocytes (CD31, CD42) are shown. Spontaneous apoptosis is defined as the degree of apoptosis of PBL incubated in the absence of MDM.59 Badley et al.
treated T cell blasts (40). Based on the above results, we ques-
tioned whether HIV-MDM triggered apoptosis of CD41 T
cells from HIV seropositive individuals is mediated through
FasL/Fas interactions. PBL from a series of 18 HIV-infected
individuals were incubated with HIV-infected MDM (HIV-
MDM). The role of FasL was analyzed by adding blocking
(M3 Fab99) or nonblocking (M33 Fab99) anti-Fas antibodies
to wells in which MDM-HIV and PBL were coincubated.
In a subgroup of patients (patients No. 1–8), Fas blocking
antibodies (M3) completely reversed the CD41 T cell apop-
tosis triggered by MDM-HIV (Fig. 4 A). However, in ad-
ditional patients, M3 incompletely reversed CD41 T cell
apoptosis (patients No. 9–14) or had no effect (patients No.
15–18). In those patient samples in which M3 blocked
HIV-MDM triggered apoptosis, the nonblocking M33 had
no effect. From these results, it is inferred that apoptosis of
CD41 T cells from HIV-infected individuals triggered by
HIV-infected MDM is partially mediated by FasL.
The above experiments were performed under alloge-
neic conditions in which MDM, obtained from healthy
HIV seronegative individuals and infected in vitro with HIV,
were coincubated with freshly isolated allogeneic PBLs
from a series of HIV-infected individuals. While FasL/Fas
interactions are presumed to be unaffected by allo-antigens,
we performed additional experiments to address this issue.
First, we determined whether lymphocyte blasts that were
generated by incubating PBL from an HIV seronegative in-
dividual with PHA and IL-2, would become apoptotic
upon incubation with syngeneic HIV-MDM. It has been
previously demonstrated that PHA–IL-2–treated lympho-
cytes become susceptible to FasL-dependent apoptosis (40).
In addition, we tested whether FasL/Fas interactions par-
ticipated in the MDM-HIV–triggered apoptosis of synge-
neic lymphocyte blasts. As shown in Fig. 4 B (left), HIV-
MDMs increased the spontaneous level of apoptosis of
syngeneic CD41 T cell blasts, an effect that was reversed by
Figure 3. Contact between HIV-MDM and PBL is required to induce apoptosis of T lymphocytes. Macrophages that were either HIV- or mock-
infected were coincubated with PBL from HIV seropositive individuals with either the two cell populations in direct contact (2), or with contact inter-
rupted (1) by a semipermeable transwell. The mean spontaneous apoptosis in these experiments was 11.0 6 3.4%.
Figure 4. (A) MDM induced apoptosis of CD41 T lymphocytes is par-
tially mediated by FasL. PBL from HIV-infected individuals were incu-
bated alone or with HIV-infected macrophages at an effector/target ratio
of 5:1, either in the absence or presence of blocking (Fab9 M3) or non-
blocking (Fab9 M33) anti-Fas antibodies (10 mg/well). In all cases, Fab9
M33 did not significantly alter the level of apoptosis seen in the PBL co-
incubated with macrophages without antibody. In order to determine the
contribution of FasL to MDM killing of PBLs, percent specific inhibition
was calculated as follows: ([apoptosis of PBL coincubated with MDM 2
apoptosis of PBL coincubated with Fab93 and MDM] [apoptosis of PBL
coincubated with MDM 2 apoptosis of PBL incubated alone]). The
mean spontaneous apoptosis was 20.7 6 13.7%. (B) Syngeneic apoptosis
of susceptible CD41 T cells by HIV-infected MDM. (Left) Lymphocyte
blasts from an HIV seronegative individual (HIV(2) BLASTS) were in-
cubated with 3 3 106 syngeneic HIV-infected MDM (HIV-MDM) either
alone ([) or in the presence of blocking (Fab9 M3) or nonblocking (Fab9
M33) antibodies (10 mg/well). Spontaneous apoptosis was calculated by
incubating PBL blasts without macrophages ([). Incubation with cross-
linked agonistic M3 anti-Fas antibody lead to 27% CD41 T cell apoptosis.
Freshly isolated PBLs had a spontaneous level of CD41 T cell apoptosis of
2% which was not modified (3%) upon coincubation with HIV-infected
MDM. (Right) Freshly isolated PBLs from an HIV-infected individual
(HIV(1)  PBL) were incubated with syngeneic HIV-infected MDMs (3 3
106) in the absence or presence of Fab M3 or M33 (10 mg/ml) antibodies.
Cross-linked M3 antibodies induced 15% of CD41 T cell apoptosis.60 Apoptosis of CD4 T Lymphocytes from HIV-infected Patients
anti-Fas blocking (M3) but not nonblocking (M33) anti-
bodies. The susceptibility of lymphocyte blasts to FasL was
confirmed by their coincubation with cross-linked anti-Fas
antibodies (see legend Fig. 4 B). This suggests that the
HIV-MDM–mediated, FasL-dependent, apoptosis of sus-
ceptible CD41 T cells can also be observed in a syngeneic
model. These observations were confirmed using MDM
and PBL obtained from an HIV seropositive individual.
MDM were HIV infected in vitro and coincubated 14 d
later with freshly isolated PBL. As shown in Fig. 4 B (right),
HIV-infected MDMs enhanced the level of spontaneous
apoptosis of freshly isolated CD41 T lymphocytes, an effect
that was reduced by anti-Fas blocking (M3), but not by
nonblocking (M33) Fab antibodies. These results suggest
that the enhanced FasL-dependent apoptosis of CD41 T cells
of this HIV-infected individual is also observed using syn-
geneic HIV-infected MDM.
TNF Participates in the MDM-triggered Apoptosis of CD41
T cells from HIV Seropositive Individuals. TNF is present as
a soluble or cell membrane bound form (6), is produced by
macrophages (42), and, as for FasL, can cause apoptosis of
activated T cells (8, 9). To determine whether TNF partic-
ipates in the apoptosis of CD41 T lymphocytes mediated
by MDM, PBLs from five HIV-infected individuals were
coincubated with uninfected and HIV-infected MDM for
48 h in the presence or absence of the human TNFRFc fu-
sion protein. This incubation period was selected to allow
for possible differences in the timing of induction of T
lymphocyte apoptosis by FasL and TNF (9). In parallel, we
tested possible additive or synergistic effects between TNF
and FasL using FasFc fusion proteins. As shown in Fig. 5,
FasFc inhibited the HIV-MDM induced apoptosis of CD41
T lymphocytes from the five HIV-infected individuals
(compare lanes 2 and 3). However, TNFRFc also reduced
CD41 T cell apoptosis from the same individuals to a simi-
lar degree to that observed with FasFc (compare lanes 2–4).
Interestingly, combining of TNFRFc and FasFc resulted in
an additive inhibition of HIV-MDM mediated apoptosis of
CD41 T cells (lane 5). CD40Fc, included to control for the
specificity of fusion protein dependent inhibition, reduced
the MDM-mediated apoptosis of CD41 T cells in three
patients, albeit to a lower degree than FasFc or TNFRFc
(lane 6). Altogether, these results indicate that FasL and
TNF participate in the selective apoptosis of CD41 T cells
from HIV-infected individuals mediated by human mac-
rophages.
Discussion
This report provides evidence of a cellular interaction
that selectively mediates CD41 T cell apoptosis of HIV-
infected, but not uninfected, individuals. This finding is
noteworthy in several regards. First, macrophage-induced
apoptosis is selective for CD41 T lymphocytes. Second,
HIV infection of macrophages further enhances CD41 T cell
apoptosis from HIV-infected individuals. Third, CD41 T cells
from HIV-infected individuals are inherently more suscep-
tible to macrophage-derived apoptosis-triggering ligands,
including FasL and TNF.
A large number of studies addressing apoptosis of PBL
from HIV-infected individuals have demonstrated that ex
vivo activation of PBL from HIV-infected individuals re-
sults in enhanced CD41, but also CD81 T cell apoptosis
(14, 15, 18, 32, 43), hence raising doubts about the rele-
vance of this observation to the in vivo CD41 T cell deple-
tion observed in HIV-infected individuals. Our results in-
dicate that macrophage-PBL interactions do not further
enhance the spontaneous apoptosis of CD81 T cells, but
selectively increases CD41 T cell apoptosis. This in vitro
finding may be of relevance to the pathogenesis of HIV
where selective CD41 T cell depletion is observed, and which
correlates with animal models of AIDS where ex vivo apop-
tosis of PBL is primarily enhanced within CD41 T cells
(18). It is possible that differences in susceptibility to mac-
rophage-bearing apoptosis-inducing ligands (FasL and TNF)
between CD41 and CD81 T cells account for such selec-
tivity. Alternatively, the frequency or affinity of the inter-
action between macrophages and CD41 T cells is higher
than between macrophages and CD81.
If interactions between macrophages and susceptible
CD41 T cells participate in CD41 T cell depletion in
HIV-infected individuals, uninfected MDM may suffice to
mediate apoptosis of susceptible CD41 T cells, and thus not
depend solely on the apoptosis-inducing capabilities of HIV-
Figure 5. FasL and TNF participate in MDM-induced apoptosis of CD41 T cells from HIV-infected individuals. 5 3 106 uninfected (NI) or HIV-
infected (HIV) macrophages were incubated with 106 PBL from five different HIV-infected individuals in the presence or absence of 20 mg FasFc,
TNFRFc, or CD40Fc or 10 mg of each of TNFRFc and FasFc for 48 h. Analysis of CD41 T cell apoptosis was done as described in Fig. 1 A. Observed
amounts of apoptosis for CD4 T cells are shown. Mean spontaneous apoptosis was 23.5 6 9.8%.61 Badley et al.
infected macrophages. Alveolar macrophages from HIV-
infected individuals are highly activated (potentially ex-
pressing apoptosis-inducing ligands) (44–48). While the role
of these macrophages in AIDS pathogenesis is unknown,
their presence correlates with decreased CD41 T cells in
alveolar fluid (49), thus suggesting that organs with high
lymphocyte toxicity such as the lung may be involved in
CD41 T cell depletion via macrophage–lymphocyte inter-
actions.
In other organs such as lymphoid tissue, uninfected anti-
gen-presenting cells but also HIV-infected macrophages,
can participate in further enhancing apoptosis of susceptible
CD41 T cells. Studies from lymph nodes indicate a by-
stander effect in the apoptosis of uninfected cells by HIV-
infected neighboring cells (17); thus, future studies should
characterize the type of HIV-infected cell that interacts
with susceptible bystander CD41 T cells. The key role of
HIV-infected macrophages in causing CD41 T cell deple-
tion is inferred from hu-SCID HIV mouse models. Mosier
et al. demonstrated that monocytotropic viruses resulted in
enhanced and accelerated apoptosis of the repopulated CD41
T cell population, suggesting that macrophages might play
an important role in CD41 T cell depletion upon HIV in-
fection (50). The enhanced FasL-dependent apoptosis of
freshly isolated CD41 T lymphocytes from HIV-infected
individuals triggered by HIV-infected MDM is most likely a
result of enhanced FasL expression or synthesis. However,
the possibility that CD41 T cells become infected during
the 24–36-h incubation period with HIV-MDM cannot be
completely excluded. The fact that uninfected MDM also
induce FasL-dependent apoptosis of CD41 T lymphocytes
from HIV-infected individuals, albeit to a lower degree
than HIV-infected MDMs, points to macrophage–related
mechanisms. Moreover, HIV infection of MDM increases
the RNA steady state levels of FasL, and this correlates
with increased apoptosis of susceptible target cells through
FasL-dependent mechanisms (40). Lastly, fixing of HIV-
infected MDMs does not abrogate the selective apoptosis of
CD41 susceptible T lymphocytes (40). The percentage of
HIV-infected MDM, as detected by intracytoplasmic p24
(which may overestimate the number of HIV-infected cells
by taking into account that MDM can phagocytize p24),
was variable in each experiment, reflecting donor variabil-
ity and macrophage susceptibility to HIV infection. This
variability of HIV infection may have impacted the range
of apoptosis observed. Additional studies are in progress to
determine whether HIV-infected macrophages and/or un-
infected macrophages present in the HIV-infected culture
is/are responsible for the enhanced apoptosis of susceptible
CD41 T lymphocytes by FasL or TNF. Additional studies
should also focus on determining which of the different
subpopulations present within MDM cultures express func-
tional apoptotic-inducing ligands.
Macrophages are thought to play a role in the physiolog-
ical CD41 T cell depletion in healthy individuals (38). Our
results support this observation, and point to macrophages
as having a major role in FasL-dependent apoptosis of sus-
ceptible CD41 T cells from HIV-infected patients (29, 30).
The state of activation, and thus of susceptibility, of the
CD41 T cell, and not the state of differentiation or HIV
infection of the macrophage, may be the critical factor reg-
ulating CD41 T cell apoptosis. Abundant data supports that
CD41 T cells from HIV-infected individuals, even at early
stages of the disease, are highly activated (51, 52). Although
the mechanism(s) leading to aberrant T cell activation in
HIV-infected individuals remain unknown, they may be
related to the degree of viral load. Decreases in viral load
correlates with decreased CD41 T cell depletion (53, 54).
If HIV-dependent mechanisms result in CD41 T cell acti-
vation and potential susceptibility to apoptosis, reductions
of viral load should decrease the state of T cell activation
and hence susceptibility to apoptosis.
Characterization of the molecules responsible for induc-
ing apoptosis of CD41 T cells from HIV-infected individu-
als is important to advance our knowledge of the cause of
CD41 T cell depletion. The participation of FasL in medi-
ating the apoptosis triggered by MDM was not unexpected
based on the recent identification of FasL in MDM (40)
and the observed enhanced susceptibility to FasL in PBL
from HIV-infected individuals (29). However, it was surpris-
ing to observe that TNF could also play a role in inducing
apoptosis of CD41 T lymphocytes from HIV-infected in-
dividuals. Recent studies indicate that Fas ligand triggers
apoptosis of T lymphocytes earlier than TNF (9). Although
we did not address this time sequence in our experimental
design, MDMs and CD41 T lymphocytes were coincu-
bated for 48 h so that the potential effect of both apoptotic
inducing ligands could be detected. The role of TNF as an
apoptotic inducing ligand in macrophages may be relevant
to HIV pathogenesis. Increased TNF and TNFR levels are
observed in HIV-infected individuals and correlate with
CD41 T cell depletion (26, 27), and our results suggest that
this receptor/ligand family may play a key role in directly
causing CD41 T cell apoptosis. Such prediction is sup-
ported by the recent observation that TNF, aside from
FasL, is partially responsible for activation-induced T lym-
phocyte apoptosis in animal models (9, 29), and that anti-
gen-induced apoptosis of CD41 T cells from HIV-infected
individuals may be mediated by TNF (55). Our results also
indicate that while Fas ligand and TNF appear to be the
major mediators of apoptosis of CD41 T lymphocytes by
MDMs, in a small number of patients, additional MDM-
mediated apoptosis independent from TNF and/or Fas
ligand was observed. This suggests that other ligands known
to induce apoptosis may play a role. TRAIL (Apo-2L) is a
new member of the TNF family with apoptotic inducing
capability (7, 55). Likewise, lymphotoxin has also been re-
cently suggested to play a role in the apoptosis of CD41 T
lymphocytes from HIV-infected individuals (56). Based on
this, additional experiments should determine whether any
of these two ligands participate in MDM-induced apoptosis
of CD41 T lymphocytes from HIV-infected individuals.
Although our study was aimed at identifying basic mech-
anisms that participate in the enhanced apoptosis of CD41
T cells, their relevance to HIV pathogenesis needs to be vali-
dated in clinical studies. Correlation of viral load and62 Apoptosis of CD4 T Lymphocytes from HIV-infected Patients
CD41 T cell number with susceptibility of CD41 T cells
to FasL and TNF needs to be established. Level and local-
ization of the expression of these ligands in lymphoid tissue
and organs from HIV-infected individuals also needs to be
addressed. Characterization of the mechanisms that lead to
enhanced susceptibility to lymphocyte apoptosis and the
abnormal regulation of apoptosis-inducing ligands in HIV-
infected patients would allow future therapeutical interven-
tions to reduce or control virus-dependent enhanced CD41
T cell depletion.
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